Abstract
Background Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools. Aims To examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics. Method Genome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts. Results Earlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (β = -0.34 years, s.e. = 0.08), major depression (β = -0.34 years, s.e. = 0.08), schizophrenia (β = -0.39 years, s.e. = 0.08), and educational attainment (β = -0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO. Conclusions AAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.
Original language | English (US) |
---|---|
Pages (from-to) | 659-669 |
Number of pages | 11 |
Journal | British Journal of Psychiatry |
Volume | 219 |
Issue number | 6 |
DOIs | |
State | Published - Dec 11 2021 |
Keywords
- Age at onset
- Bipolar disorder
- GWAS
- Polarity at onset
- Polygenic score
ASJC Scopus subject areas
- Psychiatry and Mental health
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Characterisation of age and polarity at onset in bipolar disorder'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Characterisation of age and polarity at onset in bipolar disorder. / Kalman, Janos L.; Loohuis, Loes M.Olde; Vreeker, Annabel et al.
In: British Journal of Psychiatry, Vol. 219, No. 6, 11.12.2021, p. 659-669.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Characterisation of age and polarity at onset in bipolar disorder
AU - Kalman, Janos L.
AU - Loohuis, Loes M.Olde
AU - Vreeker, Annabel
AU - McQuillin, Andrew
AU - Stahl, Eli A.
AU - Ruderfer, Douglas
AU - Grigoroiu-Serbanescu, Maria
AU - Panagiotaropoulou, Georgia
AU - Ripke, Stephan
AU - Bigdeli, Tim B.
AU - Stein, Frederike
AU - Meller, Tina
AU - Meinert, Susanne
AU - Pelin, Helena
AU - Streit, Fabian
AU - Papiol, Sergi
AU - Adams, Mark J.
AU - Adolfsson, Rolf
AU - Adorjan, Kristina
AU - Agartz, Ingrid
AU - Aminoff, Sofie R.
AU - Anderson-Schmidt, Heike
AU - Andreassen, Ole A.
AU - Ardau, Raffaella
AU - Aubry, Jean Michel
AU - Balaban, Ceylan
AU - Bass, Nicholas
AU - Baune, Bernhard T.
AU - Bellivier, Frank
AU - Benabarre, Antoni
AU - Bengesser, Susanne
AU - Berrettini, Wade H.
AU - Boks, Marco P.
AU - Bromet, Evelyn J.
AU - Brosch, Katharina
AU - Budde, Monika
AU - Byerley, William
AU - Cervantes, Pablo
AU - Chillotti, Catina
AU - Cichon, Sven
AU - Clark, Scott R.
AU - Comes, Ashley L.
AU - Corvin, Aiden
AU - Coryell, William
AU - Craddock, Nick
AU - Craig, David W.
AU - Croarkin, Paul E.
AU - Cruceanu, Cristiana
AU - Czerski, Piotr M.
AU - Dalkner, Nina
AU - Dannlowski, Udo
AU - Degenhardt, Franziska
AU - Del Zompo, Maria
AU - Depaulo, J. Raymond
AU - Djurovic, Srdjan
AU - Edenberg, Howard J.
AU - Al Eissa, Mariam
AU - Elvsåshagen, Torbjorn
AU - Etain, Bruno
AU - Fanous, Ayman H.
AU - Fellendorf, Frederike
AU - Fiorentino, Alessia
AU - Forstner, Andreas J.
AU - Frye, Mark A.
AU - Fullerton, Janice M.
AU - Gade, Katrin
AU - Garnham, Julie
AU - Gershon, Elliot
AU - Gill, Michael
AU - Goes, Fernando S.
AU - Gordon-Smith, Katherine
AU - Grof, Paul
AU - Guzman-Parra, Jose
AU - Hahn, Tim
AU - Hasler, Roland
AU - Heilbronner, Maria
AU - Heilbronner, Urs
AU - Jamain, Stephane
AU - Jimenez, Esther
AU - Jones, Ian
AU - Jones, Lisa
AU - Jonsson, Lina
AU - Kahn, Rene S.
AU - Kelsoe, John R.
AU - Kennedy, James L.
AU - Kircher, Tilo
AU - Kirov, George
AU - Kittel-Schneider, Sarah
AU - Klöhn-Saghatolislam, Farah
AU - Knowles, James A.
AU - Kranz, Thorsten M.
AU - Lagerberg, Trine Vik
AU - Landen, Mikael
AU - Lawson, William B.
AU - Leboyer, Marion
AU - Li, Qingqin S.
AU - Maj, Mario
AU - Malaspina, Dolores
AU - Manchia, Mirko
AU - Mayoral, Fermin
AU - McElroy, Susan L.
AU - McInnis, Melvin G.
AU - McIntosh, Andrew M.
AU - Medeiros, Helena
AU - Melle, Ingrid
AU - Milanova, Vihra
AU - Mitchell, Philip B.
AU - Monteleone, Palmiero
AU - Monteleone, Alessio Maria
AU - Nöthen, Markus M.
AU - Novak, Tomas
AU - Nurnberger, John I.
AU - O'Brien, Niamh
AU - O'Connell, Kevin S.
AU - O'Donovan, Claire
AU - O'Donovan, Michael C.
AU - Opel, Nils
AU - Ortiz, Abigail
AU - Owen, Michael J.
AU - Pålsson, Erik
AU - Pato, Carlos
AU - Pato, Michele T.
AU - Pawlak, Joanna
AU - Pfarr, Julia Katharina
AU - Pisanu, Claudia
AU - Potash, James B.
AU - Rapaport, Mark H.
AU - Reich-Erkelenz, Daniela
AU - Reif, Andreas
AU - Reininghaus, Eva
AU - Repple, Jonathan
AU - Richard-Lepouriel, Hélène
AU - Rietschel, Marcella
AU - Ringwald, Kai
AU - Roberts, Gloria
AU - Rouleau, Guy
AU - Schaupp, Sabrina
AU - Scheftner, William A.
AU - Schmitt, Simon
AU - Schofield, Peter R.
AU - Schubert, K. Oliver
AU - Schulte, Eva C.
AU - Schweizer, Barbara
AU - Senner, Fanny
AU - Severino, Giovanni
AU - Sharp, Sally
AU - Slaney, Claire
AU - Smeland, Olav B.
AU - Sobell, Janet L.
AU - Squassina, Alessio
AU - Stopkova, Pavla
AU - Strauss, John
AU - Tortorella, Alfonso
AU - Turecki, Gustavo
AU - Twarowska-Hauser, Joanna
AU - Veldic, Marin
AU - Vieta, Eduard
AU - Vincent, John B.
AU - Xu, Wei
AU - Zai, Clement C.
AU - Zandi, Peter P.
AU - Di Florio, Arianna
AU - Smoller, Jordan W.
AU - Biernacka, Joanna M.
AU - McMahon, Francis J.
AU - Alda, Martin
AU - Müller-Myhsok, Bertram
AU - Koutsouleris, Nikolaos
AU - Falkai, Peter
AU - Freimer, Nelson B.
AU - Andlauer, Till F.M.
AU - Schulze, Thomas G.
AU - Ophoff, Roel A.
N1 - Funding Information: Amare T. Azmeraw: has received 2020–2022 NARSAD Young Investigator Grant from the Brain & Behaviour Research Foundation. Ole A. Andreassen: speaker’s honorarium Sunovion, Lundbeck. Consultant HealthLytix. Bernhard Baune: Honoraria: Lundbeck, Janssen, LivaNova, Servier. Carrie Bearden: Novartis Scientific Advisory Board. Clark Scott: Honoraria and Investigator-initiated project funding from Jannsen-Cilag Australia, Lundbeck-Otsuka Australia. J. Raymond DePaulo: owns stock in CVS Health; JRD was unpaid consultant for Myriad Neuroscience 2017 & 2019. Michael C. O´Donovan: research unrelated to this manuscript supported by a collaborative research grant from Takeda Pharmaceuticals. Bruno Etain: honoraria for Sanofi. Mark A. Frye: grant Support Assurex Health, Mayo Foundation, Medibio Consultant (Mayo) Actify Neurotherapies, Allergan, Intra-Cellular Therapies, Inc., Janssen, Myriad, Neuralstem Inc., Sanofi, Takeda, Teva Pharmaceuticals. Per Hoffmann: employee of Life&Brain GmbH, Member of the Scientific Advisory Board of HMG Systems Engeneering GmbH. Mikael Landen: Speaker’s honoraria Lundbeck pharmaceuticals. Andrew M McIntosh: research funding from The Sackler Trust, speaker fees from Illumina and Janssen. Philip B. Mitchell: remuneration for lectures in China on bipolar disorder research by Sanofi (Hangzhou). John Nurnberger: investigator for Janssen. Benjamin M. Neale: is a member of the scientific advisory board at Deep Genomics and RBNC Therapeutics. A consultant for Camp4 Therapeutics, Takeda Pharmaceutical and Biogen. Andreas Reif: apeaker’s honoraria / Advisory boards: Janssen, Shire/Takeda, Medice, SAGE and Servier. Eli Stahl: now employed by the Regeneron Genetics Center. Kato Tadafumi: honoraria: Kyowa Hakko Kirin Co., Ltd., Eli Lilly Japan K.K., Otsuka Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., Taisho Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Meiji Seika Pharma Co., Ltd., Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Janssen Pharmaceutical K.K., Janssen Asia Pacific, Yoshitomiyakuhin, Astellas Pharma Inc., Nippon, Boehringer Ingelheim Co. Ltd., MSD K.K., Kyowa Pharmaceutical Industry Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Eisai Co., Ltd. Grants: Takeda Pharmaceutical Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation. Thomas G. Schulze: is a member of the editorial board of The British Journal of Psychiatry. He did not take part in the review or decision-making process of this paper. Eduard Vieta: has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, Sunovion and Takeda. None of the other authors reported any biomedical financial interests or potential conflicts of interest. ICMJE forms are in the supplementary material, available online at https://doi.org/10.1192/10.1192/bjp.2021.102. Publisher Copyright: Copyright © The Author(s), 2021.
PY - 2021/12/11
Y1 - 2021/12/11
N2 - Background Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools. Aims To examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics. Method Genome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts. Results Earlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (β = -0.34 years, s.e. = 0.08), major depression (β = -0.34 years, s.e. = 0.08), schizophrenia (β = -0.39 years, s.e. = 0.08), and educational attainment (β = -0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO. Conclusions AAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.
AB - Background Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools. Aims To examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics. Method Genome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts. Results Earlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (β = -0.34 years, s.e. = 0.08), major depression (β = -0.34 years, s.e. = 0.08), schizophrenia (β = -0.39 years, s.e. = 0.08), and educational attainment (β = -0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO. Conclusions AAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.
KW - Age at onset
KW - Bipolar disorder
KW - GWAS
KW - Polarity at onset
KW - Polygenic score
UR - http://www.scopus.com/inward/record.url?scp=85114705031&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114705031&partnerID=8YFLogxK
U2 - 10.1192/bjp.2021.102
DO - 10.1192/bjp.2021.102
M3 - Article
C2 - 35048876
AN - SCOPUS:85114705031
SN - 0007-1250
VL - 219
SP - 659
EP - 669
JO - British Journal of Psychiatry
JF - British Journal of Psychiatry
IS - 6
ER -